What is CanadaBis Capital Inc.?
engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
CNADF · Verdict
Moderate reward · elevated risk
CNADF stands out on volatility and growth, but watch the profitability signal.
Based on 88% data coverage
CNADF · Verdict
Top decile vs peers
Revenue +13.1% CAGR
-5% net margin · -16% ROE
-20% free-cash-flow margin
Current ratio 1.06
Model-based scoring. For information only — not financial advice.
engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.82M.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.